AzTrials
AzTrials

Surgical EmergenciesCLASSESNCT07317635

Impact of Implementing a National Classification of Surgical Emergencies on Postoperative Morbidity and Mortality: a Prospective Multicenter Observational Study After Implementation.

An observational study of Surgical Emergencies, run by Société Française d'Anesthésie et de Réanimation at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The ACUTE committee of the French Society of Anesthesia and Intensive Care (SFAR), in consultation with surgical societies, has developed a national classification of surgical emergencies to define the ideal time to surgery for each indication. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Surgical Emergencies
What is being tested?
Implementation of classification of surgical emergencies
How many people
2,500 participants
Where
1 siteFrance
Study dates
2 Feb 2026to 30 Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults under legal protection (guardianship, curatorship, or judicial safeguard) Patients who object to the reuse of their personal data for research purposes

Who may be able to join

  • Adults (≥18 years) undergoing non-cardiac emergency surgery, defined as surgery with a preoperative anesthetic consultation performed less than 48 hours before the surgical procedure.
  • Patient managed in a University Hospital (Centre Hospitalo-Universitaire) or General Hospital (Centre Hospitalier Général).
  • Patients must receive initial management and diagnosis in the emergency department of the investigating center.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • CHU Amiens-Picardie

    Amiens

    Stephane Bar, MD

Other trials in France

About this study

The ACUTE committee of the French Society of Anesthesia and Intensive Care (SFAR), in consultation with surgical societies, has developed a national classification of surgical emergencies to define the ideal time to surgery for each indication.

The goal is to integrate this classification with a cognitive aid to improve patient triage and reduce waiting times for emergency surgery.

Read more

This classification will be presented at the 2026 SFAR Congress and as a practical decision-making tool.

A prospective, multicenter study will then evaluate its impact by measuring the rate of severe postoperative complications at 30 days using the Comprehensive Complication Index (CCI).

The study will include 2500 patients over two-week periods between February and June 2027.

Expected benefits include reduced patient morbidity and hospital stay, along with better emergency surgery planning and standardization across healthcare centers.

Read the detailed description

The ACUTE committee of the French Society of Anesthesia and Intensive Care (SFAR) has developed a national classification of surgical emergencies in consultation with all surgical societies to specify the ideal time before surgery for each surgical indication. The aim is to integrate this classification with a cognitive aid to help patients consider these timeframes, based on the surgical indication, and various other factors in order to improve triage and thus reduce waiting times before emergency surgery. This classification will be presented at the 2026 SFAR Congress, as well as in the form of a cognitive aid.

Main objective To evaluate the rate of severe postoperative complications, measured using the Clavien-Dindo score and continuously expressed using the Comprehensive Complication Index (CCI), at 30 days post-surgery after implementation of the national classification of surgical emergencies.

Methods This is a prospective, observational, multicenter study. The data collection period will consist of two consecutive weeks chosen by the inclusion center within the interval between February 1, 2027, and June 30, 2027. 100 patients will be included during each period per center, for a total of 2500 patients.

Expected outcomes and benefits of the study results for patients, public health, and public policy decisions.

For patients, reducing waiting times for emergency surgery is likely to decrease morbidity and mortality, serious complications, and length of hospital stay, while increasing the number of days spent at home and limiting reoperations and rehospitalizations.

For public health, the study will:

  • document the organizational impact of national standardization;
  • reduce inter-center variability;
  • limit nighttime surgery;
  • improve emergency surgical planning.
Being tested
Implementation of classification of surgical emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implementation of classification of surgical emergenciesOther

    Observation of practices prior and after implementation of classification of surgical emergencies

Study groups in NCT07317635
Study groupRoleWhat they receive
Before integration of classification of surgical emergenciesBefore integration of classification of surgical emergencies
After integration of classification of surgical emergenciesAfter integration of a classification of surgical emergencies with a cognitive aid
Receives: Other: Implementation of classification of surgical emergencies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative morbidity and mortality

    Postoperative morbidity and mortality assessed using the Clavien-Dindo score and expressed on a continuous scale by the Comprehensive Complication Index (CCI) at 30 days (D30)Day 30

    Measured: At Day 30after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2026
  2. Study start2 Feb 2026 (estimated)
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
2,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07317635
Sponsor's protocol ID
2025-14
Acronym
CLASSES
Status last verified
Dec 2025
First submitted
19 Dec 2025
Last updated
5 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Surgical Emergencies, run by Société Française d'Anesthésie et de Réanimation at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stephane BAR, MD (+333.22.08.79.06, Bar.Stéphane@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative morbidity and mortality (time frame: At Day 30after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in